Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Apply
TER-2013
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step